Regeneron Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $378M | 672k | 562.27 |
| 2025-06-30 | $345M | 657k | 525.00 |
| 2025-03-31 | $443M | 698k | 634.23 |
| 2024-12-31 | $491M | 689k | 712.33 |
| 2024-09-30 | $752M | 715k | 1051.24 |
| 2024-06-30 | $908M | 864k | 1051.03 |
| 2024-03-31 | $853M | 887k | 962.49 |
| 2023-12-31 | $833M | 949k | 878.29 |
| 2023-09-30 | $796M | 967k | 822.96 |
| 2023-06-30 | $693M | 965k | 718.54 |
| 2023-03-31 | $817M | 994k | 821.67 |
| 2022-12-31 | $710M | 985k | 721.49 |
| 2022-09-30 | $1.0B | 1.0M | 1000.00 |
| 2022-06-30 | $566M | 958k | 591.16 |
| 2022-03-31 | $641M | 917k | 698.48 |
| 2021-12-31 | $557M | 884k | 630.43 |
| 2021-09-30 | $533M | 881k | 605.21 |
| 2021-06-30 | $480M | 859k | 558.50 |
| 2021-03-31 | $400M | 846k | 473.12 |
| 2020-12-31 | $400M | 828k | 483.03 |
| 2020-09-30 | $459M | 820k | 559.46 |
| 2020-06-30 | $481M | 773k | 622.64 |
| 2020-03-31 | $299M | 613k | 488.37 |
| 2019-12-31 | $226M | 601k | 375.48 |
| 2019-09-30 | $167M | 601k | 277.40 |
| 2019-06-30 | $189M | 603k | 313.00 |
| 2019-03-31 | $249M | 605k | 410.62 |
| 2018-12-31 | $221M | 592k | 373.50 |
| 2018-09-30 | $244M | 605k | 404.04 |
| 2018-06-30 | $206M | 597k | 344.99 |
| 2018-03-31 | $205M | 596k | 344.36 |
| 2017-12-31 | $233M | 618k | 375.96 |
| 2017-06-30 | $378M | 770k | 491.14 |
| 2017-03-31 | $342M | 882k | 387.51 |
| 2016-12-31 | $237M | 645k | 367.09 |
| 2016-09-30 | $259M | 644k | 402.02 |
| 2016-06-30 | $228M | 652k | 349.23 |